Skip to search formSkip to main contentSkip to account menu

Ramipril

Known as: Ramipril [Chemical/Ingredient], (2S-(1(R*(r*)),2alpha,3abeta,6abeta))-1-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)octahydrocyclopenta(b)pyrrole-2-carboxylic acid, Ramiprilum 
A prodrug and nonsulfhydryl angiotensin converting enzyme (ACE) inhibitor with antihypertensive activity. Ramipril is converted in the liver by de… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2008
Highly Cited
2008
BACKGROUND In patients who have vascular disease or high-risk diabetes without heart failure, angiotensin-converting-enzyme (ACE… 
Highly Cited
2006
Highly Cited
2006
BACKGROUND Previous studies have suggested that blockade of the renin-angiotensin system may prevent diabetes in people with… 
Highly Cited
2001
Highly Cited
2001
The future rate of cardiovascular events can be predicted by several well-established risk factors. Even in the absence of… 
Highly Cited
2001
Highly Cited
2001
CONTEXT Incidence of end-stage renal disease due to hypertension has increased in recent decades, but the optimal strategy for… 
Highly Cited
2001
Highly Cited
2001
Background —Activation of the renin-angiotensin-aldosterone system and oxidative modification of LDL cholesterol play important… 
Highly Cited
2000
Highly Cited
2000
BACKGROUND Angiotensin-converting-enzyme inhibitors improve the outcome among patients with left ventricular dysfunction, whether… 
Highly Cited
2000
Highly Cited
2000
than 65, and just over one-quarter were women. Most patients (80%) had a history of coronary artery disease, about half were… 
Highly Cited
1993
Highly Cited
1993
SummarySurvival after acute myocardial infarction has been enhanced by treatment with thrombolytic agents, aspirin, and Beta…